The children with a lower glucose tolerance will be randomly assigned to LibramedR treatment or placebo for 60 days (two tablets daily), after which they will repeat Anthropometric measurements, bioelectrical impedance, OGTT and blood chemistry (lipid profile, ALT and HbA1c). They will also repeat dietary and sport anamnesis .